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Introduction: Septic shock is the most severe manifestation of sepsis. It is characterized as a hypotensive
cardiovascular state associated with multiorgan dysfunction and metabolic disturbances. Management of septic
shock is targeted at preserving adequate organ perfusion pressure without precipitating pulmonary edema or
massive volume overload. Cardiac dysfunction often occurs in septic shock patients and can significantly affect
outcomes. One physiologic approach to detect the interaction between the heart and the circulation when both
are affected is to examine ventriculoarterial coupling, which is defined by the ratio of arterial elastance (Ea) to left
ventricular end-systolic elastance (Ees). In this study, we analyzed ventriculoarterial coupling in a cohort of patients
admitted to ICUs who presented with vs without septic shock.
Methods: In this retrospective cross-sectional opportunity study, we measured routine hemodynamics using
indwelling arterial and pulmonary arterial catheters and transthoracic echocardiograms in 25 septic patients
(group S) and 25 non–septic shock patients (group C) upon ICU admission. Ees was measured by echocardiography
using a single-beat (EesSB) method. Ea was calculated as 0.9 systolic arterial pressure/stroke volume, and then the
Ea/EesSB ratio was calculated (normal value <1.36).
Results: In group S, 21 patients had an Ea/EesSB ratio >1.36 (uncoupled). The four patients with Ea/EesSB
ratios ≤1.36 had higher EesSB values than patients with Ea/EesSB ratios >1.36 (P = 0.007), although Ea measurements
were similar in both groups (P = 0.4). In group C, five patients had uncoupled Ea/EesSB ratios. No correlation was
found between EesSB and left ventricular ejection fraction and between Ea/EesSB ratio and mixed venous oxygen
saturation in septic shock patients.
Conclusions: Upon admission to the ICU, patients in septic shock often display significant ventriculoarterial
decoupling that is associated with impaired left ventricular performance. Because Ea/Ees decoupling alters
cardiovascular efficiency and cardiac energetic requirements independently of Ea or Ees, we speculate that septic
patients with ventriculoarterial uncoupling may benefit from therapy aimed at normalizing the Ea/Ees ratio.Introduction
Septic shock is characterized in the resuscitated patient
as a hyperdynamic, hypotensive cardiovascular state as-
sociated with multiorgan dysfunction and metabolic dis-
turbances consistent with tissue dysoxia [1]. Importantly,
peripheral vasodilation (relative hypovolemia and low
systemic vascular resistance) can mask coexistent car-
diac dysfunction [2,3]. Cardiac dysfunction in septic
shock includes left ventricular (LV) diastolic and systolic* Correspondence: Fabiodoc64@hotmail.com
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distribution, and reproduction in any mediumdysfunction secondary to primary myocardial injury or
right ventricular dysfunction due to pulmonary hyper-
tension [4]. The combined loss of peripheral vasomotor
tone and cardiac contractile impairment may potentially
result in ventriculoarterial decoupling, the consequences
of which can be worsening cardiac energetics and
performance.
Suga and Sagawa [5] and Sunagawa et al. [6] analyzed
the circuit from the standpoint of LV ejection fraction
(LVEF). In this model, LV contractility is described by
the end-systolic pressure–volume relationship (ESPVR).
The slope of the ESPVR, called end-systolic elastance
(Ees), is a load-independent measure of cardiac contract-
ility. End-systolic pressure is also a function of both LVtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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outflow tract. The greater the SV for a given vascular
tone, the greater the systolic arterial pressure. Similarly,
increases in arterial systolic pressure for a constant pre-
load and Ees will decrease SV and increase end-systolic
volume. The slope representing the relationship between
SV and systolic arterial pressure as SV is varied is called
arterial elastance (Ea) (Figure 1). Thus, SV is both limited
and defines end-systolic pressure through arterioventricu-
lar coupling [6]. Maximal myocardial efficiency, defined as
the amount of external work performed for myocardial
oxygen consumed, occurs when Ea is approximately one-
half Ees [7] and has stronger dependence on Ea than on
Ees [8]. Accordingly, the Ea/Ees ratio is a sensitive and
independent estimate of cardiovascular efficiency [5]. A
normally coupled human cardiovascular system has an
Ea/Ees ratio = 1 ± 0.36 (median ± IQR), with normal
values being 2.2 ± 0.8 mmHg/ml for Ea and 2.3 ± 1
mmHg/ml for Ees [9].
Uncoupling, defined as an Ea/Ees ratio >1.36, can re-
sult from changes in Ea, Ees or both. Uncoupling reflects
a reduction in LV ejection efficiency, which can promote
LV energetic failure. Although septic shock is associated
with hypotension, which unloads LV ejection, it may, if
unbalanced, result in Ea/Ees decoupling. We recently
documented a primary decrease in peripheral impedance
and an increase in peripheral compliance associated with
a decrease in central aortic compliance in a porcine
model of early endotoxic shock [10]. We hypothesized
that similar Ea/Ees decoupling may also be present inFigure 1 Pressure–volume relationship in a cardiac cycle.
The slope of end-systolic elastance (Ees) (red line) represents the
end-systolic pressure–volume relationship. The slope of arterial
elastance (Ea) (green line) represents the relation between stroke
volume (SV) and left ventricular (LV) systolic pressure as SV is varied.septic patients and that this uncoupling may contribute
to the observed impaired LV ejection effectiveness.
Ea is a lumped parameter of arterial tone which is
influenced by arterial resistance and compliance, aortic
impedance and systolic and diastolic time intervals. It
reflects the net arterial load on LV ejection. Because
end-systolic pressure follows maximal ejection pressure
and end-systole occurs as LV relaxation starts, end-
systolic pressure can be approximated as 90% of systolic
arterial pressure and SV [5,6]. Similarly, Ees is defined as
the slope of the LV ESPVR derived from a series of LV
end-systolic pressure–volume points created by rapidly
varying preload or afterload such that intrinsic contract-
ility remains constant [6]. We previously showed that
end-inspiratory hold maneuvers rapidly decrease pre-
load, thus allowing the measurement of Ees [11]. Still,
the need to rapidly alter either preload or afterload and
also use invasive LV catheterization to measure LV volume
has kept the bedside measurement of Ees out of the realm
of routine bedside practice.
The demonstration that Ees can be estimated in a
single beat (EesSB) [12], and the subsequent validation of
a noninvasive echocardiographic method to measure
EesSB [13] through the measure of LVEF, SV, pre-ejection
time and systolic time interval when coupled with systolic
and diastolic arterial pressure (Figure 2), made the clinical
bedside measure possible. Thus, using these bedside esti-
mates of Ea and Ees, we measured in patients presenting
with vs without septic shock to analyze the presence of
native ventriculoarterial decoupling.
Methods
After we obtained approval from the ethical committees
for human biomedical research at both the University
Hospital of Pisa and the University of Pittsburgh, we
conducted a retrospective cross-sectional study between
July 2011 and February 2013 to elaborate hemodynamic
data obtained from (1) patients presenting with septic
shock as defined by the international consensus confer-
ence definition and treated them following the Surviving
Sepsis Campaign guidelines [14] and (2) patients admit-
ted to the ICU without presumed septic shock. Patients
with a history of cardiac disease and preoperative cardiac
surgery patients were excluded. Informed consent was
obtained from all patients, and all were studied immedi-
ately after initial fluid resuscitation in accordance with
the Surviving Sepsis Campaign guidelines, but prior to
starting therapy with any vasoactive pharmacological
agents.
We analyzed a series of measured hemodynamic vari-
ables and calculated parameters at the time of diagnosis
of septic shock in our septic shock cohort (8 women and
17 men, age 69 ± 8 years (median ± IQR)) and at the
time of ICU admission in our non–septic shock cohort
Figure 2 Left ventricular end-systolic elastance was calculated by using the single-beat method. These echocardiographic scans display
the evaluation of ejection fraction (left image) and preejection and ejection time (right image) using aortic Doppler waveforms. Normalized
ventricular elastance at arterial end-diastole (End) was measured according to the following formula:
Ees sbð Þ ¼ ½Pd−ðENd estð Þ Ps 0:9Þ=½SV  ENd estð Þ
ENd avgð Þ ¼Σai tNd
i¼ 0
ENd estð Þ ¼ 0:0275–0:165  EFþ0:3656  Pd=Pesð Þþ0:515  ENd avgð Þ
where ai values are 0.35695, −7.2266, 74.249, −307.39, 684.54. −856.92, 571.95 and −159.1 for i = 1 to i = 7, respectively. The value tNd value was
determined by the ratio of pre-ejection period (R-wave to flow onset) to total systolic period (R-wave to end-flow), with the time of onset and
termination of flow-defined Doppler. Systolic blood pressure and diastolic blood pressure were measured invasively. The single-beat method
used to calculate left ventricular end-systolic elastance was previously validated by Chen et al. [8].
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namically stable (11 women and 14 men, age 60 ± 11
years). These data included cardiac index (CI), heart rate
and mean arterial pressure (MAP) invasively measured
at a radial arterial site, as well as pulmonary artery
occlusion pressure (Ppao) and mixed venous oxygen satur-
ation (SvO2) measured using a continuous cardiac output
pulmonary artery catheter equipped with fiber optics
(Swan-Ganz oximetry thermodilution catheter; Edwards
Lifesciences, Irvine, CA, USA).
In nonseptic patients in whom a pulmonary artery
catheter was not inserted at the discretion of the at-
tending intensivist, the CI was measured using a pulse
contour method (Vigileo Monitor/FloTrac Sensor System;
Edwards Lifesciences), and central venous oxygen satur-
ation (ScvO2) was measured instead of SvO2. None of the
nonseptic patients were receiving vasoactive drug therapy
at the time they were examined.
All patients in both groups had a transthoracic echo-
cardiographic examination upon admission, all of which
were performed by the same operator. Echocardiography
was performed with a CX50 ultrasound system and an
S5-1 Sector Array Transducer (Koninklijke Philips Elec-
tronics NV, Eindhoven, the Netherlands).
Parameters calculated using data gathered from the
echocardiographic examination included LVEF, SV, pree-
jection time and systolic time. EesSB was estimated by
using the method of Chen et al. [13]. Ea was calculated
as 0.9 × (systolic arterial pressure/SV), and the Ea/EesSB
ratio was then calculated.Statistical data are expressed as median ± IQR. Con-
sidering the small number of patients in our study, a
nonparametric unpaired Mann–Whitney U test was used
to compare groups. Spearman’s coefficient of rank correl-
ation (ρ) was used to correlate variables. Fisher’s exact test
was used in the analysis of contingency tables.
Results
The data derived from 50 patients were analyzed. The
25 patients with a diagnosis of septic shock presented in
a hyperdynamic (median CI = 2.77 L/min/m2 (IQR = 2.4
to 3.8) and HR = 115 beats/min (IQR = 109 to 124),
hypotensive (MAP 58 IR 53–60) mmHg) state with a
median Ppao of 13 mmHg (IQR = 10 to 14.2), median
LVEF of 40% (IQR = 32.25 to 51.5), SvO2 of 60% (IQR =
58 to 69) and an Ea/EesSB ratio of 1.81 (IQR = 1.49 to
2.02) following initial fluid resuscitation. Only four pa-
tients had an Ea/EesSB ratio ≤1.36 at the time of diagno-
sis of septic shock, whereas the remaining twenty-one
patients had an Ea/EesSB ratio >1.36 (Figure 3). The four
patients with Ea/EesSB ratios ≤1.36 had higher EesSB
compared with twenty-one patients with Ea/EesSB ra-
tios >1.36 (P = 0.007), though Ea was similar in both the
coupled and uncoupled septic shock patients (P = 0.4). We
found no correlation between EesSB and LVEF (ρ = −0.0809,
P = 0.7007) or between Ea/EesSB ratio and SvO2 in septic
shock patients (ρ = −0.293, P = 0.15).
The 25 patients admitted in a non–septic shock state
presented with a normal systemic flow state (CI = 2.8 L/
min/m2 (IQR = 2.6 to 3)); HR = 80 beats/min (IQR = 71
Figure 3 Graphs representing the distribution of ratios of arterial elastance to single-beat end-systolic elastance in newly diagnosed
septic shock patients (A) and non–septic shock patients (B).
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of 54% (IQR = 47.5 to 58), ScvO2 = 62% (IQR = 56.8 to
69) and Ea/EesSB ratio = 1.07 (IQR = 0.95 to 1.14). Five of
these patients had a calculated Ea/EesSB ratio >1.36, and
the remaining twenty patients had Ea/EesSB ratios
<1.36 (Figure 3). Table 1 shows comparisons of variables
between septic and nonseptic patients. Compared with
non–septic shock patients, septic shock patients had
reduced Ea; lower EesSB, LVEF and MAP; and higher
Ea/EesSB ratios and HRs. Table 2 shows the absence of
correlation between Ea/EesSB status and normal or re-
duced LVEF in septic shock patients (P = 0.5) in a 2 × 2
contingency table.
Discussion
Our data show that, using bedside monitoring tech-
niques [15], most of our patients who presented to ICUs
in septic shock had significant ventriculoarterial decoup-
ling independent of the commonly seen reduced Ea,
whereas our non–septic shock patients displayed pre-
served ventriculoarterial coupling. This altered ventricu-
loarterial coupling in septic patients occurred despite a
preserved or even elevated CI. These data suggest that,
in septic shock patients, decoupling was associated withTable 1 Comparison of hemodynamic variables between sept
Measurements Septic shock patients
CI, L/min/m2 2.7 (2.4 to 3.8)
HR, beats/min 115 (109 to 124)
SAP, mmHg 85 (75 to 92)
MAP, mmHg 58 (53 to 60)
LVEF, % 40 (32 to 52)
EesSB, mmHg/ml 0.7 (0.59 to 1.1)
Ea, mmHg/ml 1.4 (1.1 to 1.48)
Ea/EesSB ratio 1.81 (1.49 to 2.03)
aCI, Cardiac index; Ea, Arterial elastance; EesSB, Single-beat ventricular end-systolic ela
pressure; SAP, Systolic arterial pressure. Data are expressed as median and IQR. P < 0.0the observed impaired LV performance and reduced Ea.
The lack of correlation between LVEF and EesSB sug-
gests that LVEF cannot be considered a clinical index of
contractility or ventricular performance. This conclusion
is not surprising, because LVEF is a function not only of
contractility but also of Ea. On the basis of these data,
we speculate that the use of vasoconstrictors in septic
shock with the aim of maintaining sufficient MAP
according to the published Surviving Sepsis Campaign
guidelines could be the cause of the reduced LVEF, as
previously suggested [3].
Ventriculoarterial decoupling is an important index of
cardiovascular inefficiency. An adequate Ea/Ees ratio is
fundamental for efficient cardiovascular performance
and is a determinant of cardiac energetics [16]. Ea/Ees
ratio reflects the interaction between cardiac function
and the arterial system that is necessary to modulate the
cardiovascular response to either physiological or
pathological conditions. The changes in CO and
vascular resistance in different physiological conditions
(for example, age, exercise, rest) and pathological condi-
tions (for example, hypertension, heart failure, diabetes)
strictly depend on both LV function and the arterial system.
Aging and cardiovascular diseases such as hypertension,ic shock and non–septic shock patientsa
Non–septic shock patients P-value
2.8 (2.6 to 3) 0.76
80 (71 to 104) <0.0001
120 (95 to 135) <0,0001
70 (67.8 to 71.3) <0.0001
54 (48 to 58) 0.0098
2.1 (1.57 to 2.3) <0.0001
2.3 (2.02 to 2.45) <0.0001
1.07 (0.95 to 1.18) 0.01
stance; HR, Heart rate; LVEF, Left ventricular ejection fraction; MAP, Mean arterial
5 was considered statistically significant.
Table 2 Analysis of correlation between ventriculoarterial






Ea/EesSB normal (<1.36), n 2 2
Ea /EesSB altered (>1.36), n 6 15
aEa, Arterial elastance; Ea/EesSB, Single-beat ventriculoarterial coupling; Ees,
End-systolic elastance; LVEF, Left ventricular ejection fraction. P = 0.5 by
Fisher’s exact test.
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valve dysfunction can alter Ea/Ees coupling by reducing LV
performance, increasing Ea or both [17].
Many researchers have shown that vasoactive drugs
can affect ventriculoarterial coupling in several differ-
ent clinical situations. The phosphodiesterase inhibitor
E-1020 was found to increase heart mechanical effi-
ciency by improving Ea/Ees coupling in heart disease
patients [18]. Levosimendan, an inodilator, restored
Ea/Ees coupling in patients with ischemic cardiomyopathy
undergoing cardiac surgery [19], and enoximone impro-
ved Ea/Ees better than dobutamine in subjects with
dilated cardiomyopathy [20,21]. Recently, Martin et al.
demonstrated a better prognosis in patients with poly-
trauma using LV stroke work and ventriculoarterial
coupling as targets of therapy [22].
Our study has some limitations. First, it is a retro-
spective analysis of prospectively collected data. Still, the
data were collected in a consistent fashion from all
participants. Second, the method we applied to measure
Ees does not take into consideration the curvilinear
shape of the elastance curve, which could be misleading
if contractility was much reduced. However, estimated
Ees values for our septic cohort were not depressed
enough to reach this region of curvilinearity. Third, the
definition of Ea was simplified as Ea = end-systolic pres-
sure/SV, but this is routinely used as a valid surrogate. Fur-
thermore, we measured arterial pressure from indwelling
radial artery catheters that may either over- or underrepre-
sent central aortic systolic pressure in septic patients. Dif-
ferences of about 10 mmHg may exist between peripheral
and central pressure sites. However, the mathematical ef-
fect of systolic arterial pressure on the calculated Ea/EesSB
would be small because it is used in the calculation of
both parameters. Fourth, we did not reanalyze our septic
patients following restoration of arterial pressure with
vasopressor agents or after recovery to see if the as-
sociated uncoupling was resolved. This latter limita-
tion forms the basis of an ongoing clinical study.
We cannot deduce the clinical implications of this
decoupling from our analysis; however, because most of
our septic shock patients had uncoupled Ea/Ees at the
time of diagnosis, we speculate that patients with septicshock and decoupled Ea/Ees would benefit from vaso-
active therapies aimed at normalizing the Ea/Ees ratio.
For example, in a murine model of sepsis, Ducrocq et al.
[23] demonstrated that increasing MAP by the use of
selective α-adrenergic vasopressors such as phenyle-
phrine will unmask LV failure. Use of a more balanced
α- and β-adrenergic agent, such as norepinephrine, may
result in a better cardiovascular state with less potential
for cardiac decompensation. Furthermore, the Surviving
Sepsis Campaign guidelines suggest using inotropes as the
last step in enhancing SvO2 values >70% [14]. We did not
find a correlation between SvO2 values and ventriculoar-
terial coupling in our septic shock patients, which is not
surprising, because, owing to possible alterations in per-
ipheral oxygen uptake, high venous oximetry cannot be
considered a good index of perfusion or cardiovascular
performance in these patients.
Conclusion
In septic shock patients, there is a higher percentage of
ventriculoarterial decoupling compared to nonseptic pa-
tients admitted to ICUs. This decoupling is associated
with impaired LV performance. Because ventriculoarterial
decoupling is an index of cardiovascular inefficiency and a
determinant of cardiac energetics, we speculate that such
“uncoupled” patients may benefit from therapies aimed at
normalizing the Ea/Ees ratio. However, this hypothesis
remains to be tested.
Key messages
 Ea and LV Ees can be measured at the bedside in
critically ill patients.
 Septic shock affects both ventricular and arterial
elastance.
 Disproportionate changes in either ventricular or
arterial elastance will lead to ventriculoarterial
decoupling.
 Therapies aimed at normalizing the Ea/Ees ratio
may improve cardiovascular efficiency.
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